Kingsview Wealth Management, LLC Bio N Tech Se Transaction History

Kingsview Wealth Management, LLC

  • $4.45 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$123.25 - $186.24 $206,443 - $311,952
-1,675 Closed
0 $0
Q4 2021

Feb 17, 2022
SELL
$216.64 - $362.52 $258,451 - $432,486
-1,193 Reduced 41.6%
1,675 $432,000
Q3 2021

Dec 03, 2021
BUY
$205.93 - $447.23 $590,607 - $1.28 Million
2,868 New
2,868 $783,000

Others Institutions Holding BNTX

# of Institutions
357
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.8B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Kingsview Wealth Management, LLC Portfolio

Follow Kingsview Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsview Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsview Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email